Molecular characterization of mupirocin-resistant MRSA from Germany and South Africa.

doi:10.3389/fcimb.2026.1865925

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Molecular characterization of mupirocin-resistant MRSA from Germany and South Africa.

Frontiers in cellular and infection microbiology - 1 Jan 2026

Shittu Adebayo Osagie, Perovic Olga, Layer-Nicolaou Franziska, Strommenger Birgit, Adesoji Tomiwa Olumide, Sulayman Taofiq Adewale, Afolayan Ayorinde Oluwatobiloba, Mellmann Alexander, Schaumburg Frieder

Abstract excerpt

Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is a human pathogen of global public health importance. A key element of MRSA decolonization strategies is the administration of mupirocin, an antibiotic also used to treat superficial skin infections. However, the emergence and global increase of mupirocin-resistant (mupR)-MRSA highlight the need for active surveillance to support evidence-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Toxins
Share to Exotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to Leukocidins

Share to Methicillin-Resistant Staphylococcus aureus

Share to South Africa

Share to Staphylococcal Infections

Share to Virulence Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 42643317
DOI: 10.3389/fcimb.2026.1865925
PMCID: PMC13503169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.